Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

[Two Cases of Recurrent Colon Cancer with BRAF Mutation].

Gan to kagaku ryoho. Cancer & chemotherapy - 1 Dec 2022

Fujie Yujiro, Nishimura Hiroshi, Sata Atsushi, Adachi Shinichi, Higaki Naozumi, Ueshima Shigeyuki, Hayashida Hirohito, Ohnishi Tadashi

Abstract excerpt

We report 2 cases of recurrent colon cancer with BRAF mutation. Case 1, a 75-year-old man, had rapid progress of multiple liver metastasis 5 months after curative resection, and died on 37 days after recurrence without induction of systemic therapy. Case 2, a 67-year-old man with diagnosis of peritoneal dissemination at 8 months after curative resection, received encorafenb and cetuximab (doublet-therapy) with...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Aged
Share to Antineoplastic Combined Chemotherapy Protocols

Methodology Data sources Editorial policy Privacy About Contact Helena Bioinformatics

Share to Colonic Neoplasms

Share to Colorectal Neoplasms

Share to Mutation

Share to Neoplasm Recurrence, Local

Share to Proto-Oncogene Proteins B-raf

Source

Identifiers

PMID: 36733110

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 6 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

[Two Cases of Recurrent Colon Cancer with BRAF Mutation].PMID 36733110Read ↗

A multiple metastatic colon cancer patient with extra-long survival and acquired BRAF mutation: case report and literature reviewSemantic proximity Read ↗

Successful treatment of metastatic colorectal cancer with synchronous BRAF V600E mutation and dMMR with BGB-A317.Semantic proximity Read ↗

Synchronous Colorectal Carcinoma: Three Cases Report and Literature ReviewSemantic proximity Read ↗

Response to crizotinib + regorafenib + PD-1 inhibitor in a metastatic BRAF V600E MT colon cancer patients with acquired C-MET amplification and TPM4- ALK fusion: case report and review of literatureSemantic proximity Read ↗

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon CancersSemantic proximity Read ↗

The Effect of RAS/BRAF Mutation Status on Prognosis and Relapse Pattern in Early Stage Colon Cancers.Semantic proximity Read ↗

[A Case of BRAF Mutant Cecal Cancer Treated with Encorafenib, Binimetinib, and Cetuximab Triple Therapy].Semantic proximity Read ↗

[A Case of BRAF V600E-Mutant Colorectal Cancer Treated Effectively by Encorafenib, Binimetinib, and Cetuximab Triple Therapy].Semantic proximity Read ↗

[Long-Term Survival of a Patient with KRAS Mutated Colon Cancer Successfully Treated with Regorafenib].Semantic proximity Read ↗

[Alternations of p53 gene, microsatellite instability and proliferation associated antigen Ki-67 in the synchronous multiple colorectal cancers].Semantic proximity Read ↗

[Efficacy and safety of cetuximab+irinotecan for unresectable advanced or recurrent colorectal cancer].Semantic proximity Read ↗

[Impacts of microsatellite status, RAS and BRAF mutation on postoperative follow-up strategy in stage II( and III( colorectal cancer].Semantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.